Simplex Trading’s Audentes Therapeutics, Inc BOLD Stock Holding History

Simplex Trading’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-213	Closed	-$1.27M	–	8716
2019 Q4	$1.27M	Buy	213 +145	+213%	+$5.44K	﹤0.01%	1868
2019 Q3	$191K	Buy	68 +8	+13%	+$273	﹤0.01%	3606
2019 Q2	$227K	Sell	60 -21	-26%	-$807	﹤0.01%	3337
2019 Q1	$316K	Buy	81 +73	+913%	+$2.09K	﹤0.01%	3141
2018 Q4	$17K	Sell	8 -12	-60%	-$310	﹤0.01%	5484
2018 Q3	$79K	Buy	+20	New	+$746	﹤0.01%	4695
2018 Q2	–	Sell	-22	Closed	-$3K	–	8179
2018 Q1	$3K	Buy	+22	New	+$745	﹤0.01%	5141

Simplex Trading's BOLD Position: Q1 2020 in Review

Simplex Trading sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 470 shares — an estimated $28K sold.

Simplex Trading first reported a position in BOLD in Q1 2018 and held it in 6 quarters. The position peaked at $213K in Q2 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Simplex Trading reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Simplex Trading sold 470 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $28K.
Simplex Trading first reported a position in Audentes Therapeutics, Inc in Q1 2018 and held it in 6 quarters.
Simplex Trading's Audentes Therapeutics, Inc position peaked at $213K in Q2 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Simplex Trading's 13F filing for Q1 2020, filed 29 Apr 2020.